Advanced in Dysferlinopathy

Dr. Kevin M. Flanigan

Pediatric Neurology | Neurology
433 N Cleveland Ave, 
Westerville, OH 
Clinical Trials:Currently Recruiting for 1 Trial
Accepting New Patients
Advanced in Dysferlinopathy
433 N Cleveland Ave, 
Westerville, OH 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Kevin Flanigan is a Pediatric Neurologist and a Neurologist in Westerville, Ohio. Dr. Flanigan is rated as an Advanced provider by MediFind in the treatment of Dysferlinopathy. His top areas of expertise are Becker Muscular Dystrophy, Duchenne Muscular Dystrophy, Dystrophinopathy, and Vici Syndrome. Dr. Flanigan is currently accepting new patients.

His clinical research consists of co-authoring 137 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Pediatric Neurology
Neurology
Licenses
Neurology with Special Qualifications in Neurology in OH
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Rocky Mountain Health Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
View 5 Less Insurance Carriers -

Locations

433 N Cleveland Ave, Westerville, OH 43082
Other Locations
555 S 18th St, Columbus, OH 43205
6435 E Broad St, Columbus, OH 43213
5675 Venture Dr, Dublin, OH 43017
536 S Trimble Rd, Mansfield, OH 44906
3949 N Main St, Findlay, OH 45840
455 Executive Campus Dr, Westerville, OH 43082

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

Phase I/II/III Gene Transfer Clinical Trial of scAAV9.U1a.hSGSH for Mucopolysaccharidosis (MPS) IIIA
Phase I/II/III Gene Transfer Clinical Trial of scAAV9.U1a.hSGSH for Mucopolysaccharidosis (MPS) IIIA
Enrollment Status: Recruiting
Publish Date: July 17, 2025
Intervention Type: Drug, Biological
Study Drug: ABO-102
Study Phase: Phase 2/Phase 3
A Long-term Follow-up Study of Patients With MPS IIIA From Gene Therapy Clinical Trials Involving the Administration of ABO-102 (scAAV9.U1a.hSGSH)
A Long-term Follow-up Study of Patients With MPS IIIA From Gene Therapy Clinical Trials Involving the Administration of ABO-102 (scAAV9.U1a.hSGSH)
Enrollment Status: Enrolling_by_invitation
Publish Date: July 18, 2025
Intervention Type: Other, Drug
Study Phase: Phase 3
A Phase 3, Randomized, Double-blind, Placebo-controlled Efficacy and Safety Study of Ataluren in Patients With Nonsense Mutation Duchenne Muscular Dystrophy and Open-Label Extension
A Phase 3, Randomized, Double-blind, Placebo-controlled Efficacy and Safety Study of Ataluren in Patients With Nonsense Mutation Duchenne Muscular Dystrophy and Open-Label Extension
Enrollment Status: Completed
Publish Date: January 18, 2024
Intervention Type: Drug
Study Drug: Ataluren
Study Phase: Phase 3
Duchenne Muscular Dystrophy: Double-blind Randomized Trial to Find Optimum Steroid Regimen
Duchenne Muscular Dystrophy: Double-blind Randomized Trial to Find Optimum Steroid Regimen
Enrollment Status: Completed
Publish Date: August 12, 2022
Intervention Type: Drug
Study Phase: Phase 3
A Long-term Follow-up Study of Patients With MPS IIIB From Gene Therapy Clinical Trials Involving the Administration of ABO-101 (rAAV9.CMV.hNAGLU)
A Long-term Follow-up Study of Patients With MPS IIIB From Gene Therapy Clinical Trials Involving the Administration of ABO-101 (rAAV9.CMV.hNAGLU)
Enrollment Status: Terminated
Publish Date: May 31, 2022
Intervention Type: Biological
Phase I/II Gene Transfer Clinical Trial of rAAV9.CMV.hNAGLU for Mucopolysaccharidosis (MPS) IIIB
Phase I/II Gene Transfer Clinical Trial of rAAV9.CMV.hNAGLU for Mucopolysaccharidosis (MPS) IIIB
Enrollment Status: Terminated
Publish Date: May 05, 2022
Intervention Type: Biological
Study Drug: rAAV9.CMV.hNAGLU
Study Phase: Phase 1/Phase 2
View 5 Less Clinical Trials

137 Total Publications

Consensus recommendations and considerations for the delivery and monitoring of gene therapy in patients with Duchenne muscular dystrophy.
Consensus recommendations and considerations for the delivery and monitoring of gene therapy in patients with Duchenne muscular dystrophy.
Journal: Neuromuscular disorders : NMD
Published: June 17, 2025
Similar Doctors
Elite in Dysferlinopathy
Dr. Jerry R. Mendell
Neurology
Elite in Dysferlinopathy
Dr. Jerry R. Mendell
Neurology
700 Childrens Dr, 
Columbus, OH 
 (12.9 miles away)
614-355-3574
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Dr. Jerry Mendell, MD is a Neurology Specialist in Columbus, OH and has over 56 years of experience in the medical field. He graduated from University of Texas Southwestern Medical School in 1966. Dr. Mendell is rated as an Elite provider by MediFind in the treatment of Dysferlinopathy. His top areas of expertise are Duchenne Muscular Dystrophy, Becker Muscular Dystrophy, Limb-Girdle Muscular Dystrophy, and Spinal Muscular Atrophy (SMA).

Experienced in Dysferlinopathy
Dr. Anne M. Connolly
Pediatric Neurology | Neurology
Experienced in Dysferlinopathy
Dr. Anne M. Connolly
Pediatric Neurology | Neurology
5675 Venture Dr, 
Dublin, OH 
 (10.7 miles away)
614-722-6200
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Anne Connolly is a Pediatric Neurologist and a Neurologist in Dublin, Ohio. Dr. Connolly is rated as a Distinguished provider by MediFind in the treatment of Dysferlinopathy. Her top areas of expertise are Becker Muscular Dystrophy, Duchenne Muscular Dystrophy, Spinal Muscular Atrophy (SMA), and Primary Lateral Sclerosis. Dr. Connolly is currently accepting new patients.

Advanced in Dysferlinopathy
Dr. Michael C. Isfort
Neurology
Advanced in Dysferlinopathy
Dr. Michael C. Isfort
Neurology

Osu Neuroscience Center, LLC

2050 Kenny Rd, 
Columbus, OH 
 (10.4 miles away)
614-293-4969
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Michael Isfort is a Neurologist in Columbus, Ohio. Dr. Isfort is rated as an Advanced provider by MediFind in the treatment of Dysferlinopathy. His top areas of expertise are Facioscapulohumeral Muscular Dystrophy (FSHD), Dysferlinopathy, Paramyotonia Congenita, and Myotonic Dystrophy Type 2. Dr. Isfort is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Flanigan's expertise for a condition
ConditionClose
View All 9 Advanced Conditions
View All 43 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile